Prospective clinical study of oocyte and/or ovarian tissue cryopreservation in patients with endometriosis

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100053366

Enrollment

Unknown

Registered

2021-11-20

Start date

2020-07-01

Completion date

Unknown

Last updated

2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

cryopreservation of oocytes:cryopreservation of oocytes

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria for cryopreservation of oocytes: 1.Aged = 4cm; 4.Who are able to tolerate ovulation induction and vaginal egg-extraction procedures; 5.Voluntarily participate in this study, sign informed consent, good compliance, and follow up. Inclusion criteria for cryopreservation of ovarian tissue: 1. Aged = 4cm, 4. With normal ovarian reserve function 5. Able to tolerate laparoscopic surgery 6. Able to understand and be willing to provide written informed consent and to comply with study requirements.

Exclusion criteria

Exclusion criteria: 1. Patients with infectious diseases (HIV, syphilis, hepatitis, etc.); 2. Patients with surgery or anesthesia contraindication; 3. Patients with mental disorders or family history of mental diseases; 4. Other conditions that do not conform to laws, regulations or ethics.

Design outcomes

Primary

Measure	Time frame
reproductive outcome;	—

Secondary

Measure	Time frame
Reproductive endocrine function;	—

Countries

China

Contacts

Public ContactXu congjian

OBGYN hospital of Fudan University

xucongjian1275@fckyy.org.cn13651796353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026